Infy says it might not make as much money as it thought. Revenues at lower end of guidance, clients aren’t spending. Stock down 8%. (SmartInvestor)
Sun Pharma sees the FDA put an import alert on the Karkhadi plant and the stock’s down 3.5%. (Economic Times) Wonder why it’s singled out in this fall – mentioned in the FDA report are: Ranbaxy (all plants), Aurobindo Pharma (1 plant, stock is up!), Wockhardt (2 plants).
New Zealand is the first developed country to raise rates (Bloomberg)
Mutual funds find it difficult to oppose the Maruti Suzuki Gujarat plant but still ask Maruti to park excess cash in its debt schemes (Investors are idiots)
How to tell when the bull market is turning bear (LiveMint)